SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-18-042519
Filing Date
2018-11-06
Accepted
2018-11-06 16:28:06
Documents
5
Period of Report
2018-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 29297
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 176460
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 40895
4 image00001.jpg GRAPHIC 2133
5 image00002.jpg GRAPHIC 2164
  Complete submission text file 0001140361-18-042519.txt   254071
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 181163364
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1